BLFS Revenue Forecast
BLFS EPS Forecast
BLFS FAQs
What is revenue forecast for next quarter？
BLFS Analyst's Forecast
Paul Knight
Keybanc
Buy
Price Target
$30 → $33
Upside
+24.29%
KeyBanc raised the firm's price target on BioLife Solutions to $33 from $30 and keeps an Overweight rating on the shares. BioLife, under its new CEO, has completed a quick succession of three asset sales, and the firm's proforma models show a high-growth and high-margin business with its dominance of freeze media for the cell, gene, and CAR-T markets, the analyst tells investors in a research note.
Steven Mah
TD Cowen
Strong Buy
Price Target
$28 → $31
Upside
+26.53%